Croda International Plc is a UK‑headquartered specialty chemicals and ingredients company serving consumer care, life sciences, and selected industrial markets worldwide. Founded in 1925 and listed on the London Stock Exchange, the company develops high‑value materials used in personal care, crop protection and seed enhancement, pharmaceuticals and biopharmaceutical manufacturing, and other niche applications.
Its portfolio spans surfactants, emollients, and active ingredients for cosmetics and skin care; adjuvants, seed‑applied technologies, and formulation aids for agrochemicals; high‑purity excipients and lipid delivery systems for biologics and vaccines; and specialty additives for coatings, polymers, and lubricants. Croda emphasizes bio‑based feedstocks, biotechnology, and green chemistry, supported by a global network of R&D centers and manufacturing sites.
chemXplore tracks 5 projects involving Croda.
Croda's role on them: Owner, Investor / Financier, Operator, and Developer.
New R&D labs at Sci‑Tech Daresbury will act as a global biotechnology research centre to speed development and commercialisation of next‑generation ingredients and support regional job growth.
Group organic sales +4.6% in H1; adjusted operating profit £155.8m; free cash flow up 36.8%; FY26 guidance unchanged with 3–6% organic range.
Co-locates actives and fragrance teams to accelerate regional innovation, formulation support, local botanical sourcing, perfumery capacity and supply resilience across Asia.
Patent-pending botanical active derived from Chinese mallow supports firmness, hydration, elasticity and facial volume; clinically validated and COSMOS/RSPO/Halal certified.
Adds advanced lipid technologies offering improved stability and enabling new delivery routes for mRNA, protein and peptide therapeutics; initially for research use with scale-up development.
New programme targets zero‑impact beauty across six pillars (NetZero, Waste, Biodiversity, Water, Exploitation, Ambiguity) using biotech ingredients, renewable sourcing, LCA metrics & circularity.
Q1 sales £431m, +1% CC; Beauty Actives and F&F offset weaker Crop Protection. Transformation on track; FY26 outlook unchanged. Latin America strongest; North America weaker.
Patented encapsulation enables controlled peptide release up to 15 days, visible firming (25% in 2 weeks), microneedling synergy (+31% collagen‑III), 99.8% natural, vegan and lower carbon footprint.
By country, the most active first. active / all projects
